Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Effect of lamotrigine on in vivo and in vitro cytokine secretion in murine model of inflammation.

Abu-Rish EY, Dahabiyeh LA, Bustanji Y, Mohamed YS, Browning MJ.

J Neuroimmunol. 2018 Sep 15;322:36-45. doi: 10.1016/j.jneuroim.2018.06.008. Epub 2018 Jun 11.

PMID:
29937116
2.

Vitamin D3 supplementation of a high fat high sugar diet ameliorates prediabetic phenotype in female LDLR-/- and LDLR+/+ mice.

Kheder R, Hobkirk J, Saeed Z, Janus J, Carroll S, Browning MJ, Stover C.

Immun Inflamm Dis. 2017 Jun;5(2):151-162. doi: 10.1002/iid3.154. Epub 2017 Mar 13.

3.

Tumour cell conditioned medium reveals greater M2 skewing of macrophages in the absence of properdin.

Al-Rayahi IA, Browning MJ, Stover C.

Immun Inflamm Dis. 2017 Jan 26;5(1):68-77. doi: 10.1002/iid3.142. eCollection 2017 Mar.

4.

The in vitro generation of multi-tumor antigen-specific cytotoxic T cell clones: Candidates for leukemia adoptive immunotherapy following allogeneic stem cell transplantation.

Mohamed YS, Bashawri LA, Vatte C, Abu-Rish EY, Cyrus C, Khalaf WS, Browning MJ.

Mol Immunol. 2016 Sep;77:79-88. doi: 10.1016/j.molimm.2016.07.012. Epub 2016 Aug 1.

PMID:
27490939
5.

Cowden's syndrome with immunodeficiency.

Browning MJ, Chandra A, Carbonaro V, Okkenhaug K, Barwell J.

J Med Genet. 2015 Dec;52(12):856-9. doi: 10.1136/jmedgenet-2015-103266. Epub 2015 Aug 5.

6.

On the Functional Overlap between Complement and Anti-Microbial Peptides.

Zimmer J, Hobkirk J, Mohamed F, Browning MJ, Stover CM.

Front Immunol. 2015 Jan 19;5:689. doi: 10.3389/fimmu.2014.00689. eCollection 2014. Review.

7.

Pneumococcal polysaccharide vaccine responses are impaired in a subgroup of children with cystic fibrosis.

Browning MJ, Lim MT, Kenia P, Whittle M, Doffinger R, Barcenas-Morales G, Kumararatne D, Viskaduraki M, O'Callaghan C, Gaillard EA.

J Cyst Fibros. 2014 Dec;13(6):632-8. doi: 10.1016/j.jcf.2014.02.002. Epub 2014 Mar 11.

8.

Antigen presenting cell/ tumor cell fusion vaccines for cancer immunotherapy.

Browning MJ.

Hum Vaccin Immunother. 2013 Jul;9(7):1545-8. doi: 10.4161/hv.24235. Epub 2013 Mar 8. Review.

9.

Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.

Abu-Rish EY, Amrani Y, Browning MJ.

Rheumatology (Oxford). 2013 Jul;52(7):1190-201. doi: 10.1093/rheumatology/ket006. Epub 2013 Feb 21.

PMID:
23436580
10.

In vitro evaluation of human hybrid cell lines generated by fusion of B-lymphoblastoid cells and ex vivo tumour cells as candidate vaccines for haematological malignancies.

Mohamed YS, Dunnion D, Teobald I, Walewska R, Browning MJ.

Vaccine. 2012 Oct 12;30(46):6578-87. doi: 10.1016/j.vaccine.2012.08.032. Epub 2012 Aug 30.

PMID:
22939910
11.

Long-lived fusions of human haematological tumour cells and B-lymphoblastoid cells induce tumour antigen-specific cytotoxic T-cell responses in vitro.

Mohamed YS, Dunnion D, Teobald I, Walewska R, Browning MJ.

Immunobiology. 2012 Jul;217(7):719-29. doi: 10.1016/j.imbio.2011.12.001. Epub 2011 Dec 8.

PMID:
22305004
12.

Specific antibody deficiency in children with chronic wet cough.

Lim MT, Jeyarajah K, Jones P, Pandya H, Doffinger R, Kumararatne D, Browning MJ, Gaillard EA.

Arch Dis Child. 2012 May;97(5):478-80. doi: 10.1136/archdischild-2011-300691. Epub 2012 Jan 30.

PMID:
22294669
13.

Conjugation of testosterone modifies the interaction of mono-functional cationic platinum(II) complexes with DNA, causing significant alterations to the DNA helix.

Sanchez-Cano C, Huxley M, Ducani C, Hamad AE, Browning MJ, Navarro-Ranninger C, Quiroga AG, Rodger A, Hannon MJ.

Dalton Trans. 2010 Dec 21;39(47):11365-74. doi: 10.1039/c0dt00839g. Epub 2010 Oct 29.

PMID:
21031219
14.

An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(II) metallo-drug.

Huxley M, Sanchez-Cano C, Browning MJ, Navarro-Ranninger C, Quiroga AG, Rodger A, Hannon MJ.

Dalton Trans. 2010 Dec 21;39(47):11353-64. doi: 10.1039/c0dt00838a. Epub 2010 Oct 29.

PMID:
21031218
15.
16.

A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.

Assaf A, Esteves H, Curnow SJ, Browning MJ.

Cell Immunol. 2009;259(1):90-9. doi: 10.1016/j.cellimm.2009.06.003. Epub 2009 Jun 6.

PMID:
19573862
17.

Expression of chemokine receptors CXCR4, CXCR5 and CCR7 on B and T lymphocytes from patients with primary antibody deficiency.

Payne D, Drinkwater S, Baretto R, Duddridge M, Browning MJ.

Clin Exp Immunol. 2009 May;156(2):254-62. doi: 10.1111/j.1365-2249.2009.03889.x. Epub 2009 Jan 22.

18.

T-cell immunodeficiency in CHARGE syndrome.

Chopra C, Baretto R, Duddridge M, Browning MJ.

Acta Paediatr. 2009 Feb;98(2):408-10. doi: 10.1111/j.1651-2227.2008.01077.x. Epub 2008 Oct 13.

PMID:
18976358
19.

Phenotypic and functional differentiation of KG-1 into dendritic-like cells.

Teobald I, Dunnion DJ, Whitbread M, Curnow SJ, Browning MJ.

Immunobiology. 2008;213(1):75-86. doi: 10.1016/j.imbio.2007.06.001. Epub 2007 Aug 1.

PMID:
18207029
21.

Mechanisms of the self/non-self-survey in the defense against cancer: potential for chemoprevention?

Sharma RA, Browning MJ.

Crit Rev Oncol Hematol. 2005 Oct;56(1):5-22. Review.

PMID:
15978831
22.

Graves' disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion.

Brown JJ, Datta V, Browning MJ, Swift PG.

J Pediatr Endocrinol Metab. 2004 Nov;17(11):1575-9.

PMID:
15570997
23.

Lymphocyte subpopulations from patients with primary antibody deficiency do not show increased telomere erosion.

Tucker VC, Rye AD, Harrison J, King L, Duddridge M, Browning MJ.

Immunobiology. 2004;208(5):455-62.

PMID:
15124860
24.

T-cell telomere length maintained in HIV-infected long-term survivors.

Tucker V, Jenkins J, Gilmour J, Savoie H, Easterbrook P, Gotch F, Browning MJ.

HIV Med. 2000 Mar;1(2):116-22.

25.

The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease.

O'Byrne KJ, Dalgleish AG, Browning MJ, Steward WP, Harris AL.

Eur J Cancer. 2000 Jan;36(2):151-69. Review.

PMID:
10741273
26.

A coughing policeman.

Duddridge M, West KP, Wales J, Browning MJ.

Lancet. 2000 Mar 4;355(9206):804. No abstract available.

PMID:
10711929
27.

Human antigen-presenting cell/tumour cell hybrids stimulate strong allogeneic responses and present tumour-associated antigens to cytotoxic T cells in vitro.

Dunnion DJ, Cywinski AL, Tucker VC, Murray AK, Rickinson AB, Coulie P, Browning MJ.

Immunology. 1999 Dec;98(4):541-50.

29.

The McCoy laryngoscope blade.

Browning MJ.

Anaesthesia. 1997 Feb;52(2):185. No abstract available.

30.

HLA-A2 polymorphism and immune functions.

Krausa P, Browning MJ.

Eur J Immunogenet. 1996 Aug;23(4):261-74. Review. No abstract available.

PMID:
8858283
31.

A comprehensive PCR-SSP typing system for identification of HLA-A locus alleles.

Krausa P, Browning MJ.

Tissue Antigens. 1996 Mar;47(3):237-44. No abstract available.

PMID:
8740775
32.

Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes.

Toshitani K, Braud V, Browning MJ, Murray N, McMichael AJ, Bodmer WF.

Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):236-40.

33.

Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).

Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI.

Tissue Antigens. 1995 Nov;46(5):355-67.

PMID:
8838344
34.

Defining the allelic variants of HLA-A30 in the Sardinian population using amplification refractory mutation system--polymerase chain reaction.

Krausa P, Carcassi C, OrrĂ¹ S, Bodmer JG, Browning MJ, Contu L.

Hum Immunol. 1995 Sep;44(1):35-42.

PMID:
8522453
35.

Rapid characterization of HLA class I alleles by gene mapping using ARMS PCR.

Krausa P, Barouch D, Bodmer JG, Browning MJ.

Eur J Immunogenet. 1995 Jun;22(3):283-7. No abstract available.

PMID:
8547235
36.

The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles.

Browning MJ, Madrigal JA, Krausa P, Kowalski H, Allsopp CE, Little AM, Turner S, Adams EJ, Arnett KL, Bodmer WF, et al.

Tissue Antigens. 1995 Mar;45(3):177-87.

PMID:
7761977
37.

Characterization of a novel HLA-A2 variant, A*0214, by ARMS-PCR and DNA sequencing.

Krausa P, Barouch D, Bodmer JG, Hill AV, Mason C, McMichael AJ, Browning MJ.

Immunogenetics. 1995;41(1):50. No abstract available.

PMID:
7806276
38.

Identification of a novel HLA-A2 subtype, HLA-A*0216.

Barouch D, Krausa P, Bodmer J, Browning MJ, McMichael AJ.

Immunogenetics. 1995;41(6):388. No abstract available.

PMID:
7759139
39.

Low-resolution DNA typing for HLA-B using sequence-specific primers in allele- or group-specific ARMS/PCR.

Sadler AM, Petronzelli F, Krausa P, Marsh SG, Guttridge MG, Browning MJ, Bodmer JG.

Tissue Antigens. 1994 Sep;44(3):148-54.

PMID:
7839346
40.

HLA-A locus DNA typing of the 4AOH cell panel by arms PCR.

Krausa P, Browning MJ, Moses JH, Bodmer JG.

Eur J Immunogenet. 1994 Jun;21(3):199-204.

PMID:
9098433
41.

Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy.

Browning MJ, Krausa P, Rowan A, Hill AB, Bicknell DC, Bodmer JG, Bodmer WF.

J Immunother Emphasis Tumor Immunol. 1993 Oct;14(3):163-8.

PMID:
8297898
42.

Tumor escape from immune response by variation in HLA expression and other mechanisms.

Bodmer WF, Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG.

Ann N Y Acad Sci. 1993 Aug 12;690:42-9. Review. No abstract available.

PMID:
8368769
43.

Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR.

Krausa P, Bodmer JG, Browning MJ.

Tissue Antigens. 1993 Aug;42(2):91-9.

PMID:
8266322
44.

Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines.

Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF.

Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2842-5.

45.

A recombinant feline immunodeficiency virus envelope fusion protein stimulates peripheral blood lymphocytes from naive cats to proliferate in vitro.

Beatty JA, Reid G, Rigby MA, Neil JC, Jarrett O, Browning MJ.

Vet Immunol Immunopathol. 1992 Dec;35(1-2):143-53.

PMID:
1337393
46.

MHC antigens and cancer: implications for T-cell surveillance.

Browning MJ, Bodmer WF.

Curr Opin Immunol. 1992 Oct;4(5):613-8. Review.

PMID:
1418728
47.

Replication-defective viruses modulate immune responses.

Browning MJ, Huneycutt BS, Huang AS, Reiss CS.

J Immunol. 1991 Oct 15;147(8):2685-91.

PMID:
1655896
49.

Vaccine-induced polioencephalomyelitis in Scotland.

Asindi AA, Bell EJ, Browning MJ, Stephenson JB.

Scott Med J. 1988 Aug;33(4):306-7.

PMID:
2847313
50.

Genetic control of oral tolerance to ovalbumin in mice.

Lamont AG, Mowat AM, Browning MJ, Parrott DM.

Immunology. 1988 Apr;63(4):737-9.

Supplemental Content

Loading ...
Support Center